1887
Research Open Access
Like 0

Abstract

BACKGROUND

has emerged globally as a major threat to public health due to its outbreak causing capacity and antifungal resistance. Outbreaks have proven difficult to control despite enhanced infection prevention measures. Thus, national surveillance is warranted.

AIM

We aim to characterise the epidemiology of cases in Czechia between 2022 and 2024 to investigate whether autochthonous spread is occurring and asses antifungal resistance.

METHODS

High-resolution genotyping was performed to assess genetic relatedness between isolates. Microbroth dilution was performed on all isolates and underlying mechanisms resistance were inspected with whole genome sequencing.

RESULTS

Eight cases from seven different hospitals were reported, mainly collected from non-sterile sites, in addition to the first documented prosthetic joint infection by . Only two patients reported travel history. Three clades were found, with the first report of Clade IV in Europe. For one patient, initial isolates were pan-susceptible but after short exposure to fluconazole became resistant with a novel mechanism.

CONCLUSION

reported in Czechia in patients without travel history suggests autochthonous spread. Three clades were present, often with unknown route of introduction. Development of fluconazole resistance upon brief exposure highlights the ability of to rapidly evolve.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.45.2500285
2025-11-13
2025-12-05
/content/10.2807/1560-7917.ES.2025.30.45.2500285
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/45/eurosurv-30-45-6.html?itemId=/content/10.2807/1560-7917.ES.2025.30.45.2500285&mimeType=html&fmt=ahah

References

  1. Lionakis MS, Chowdhary A. Candida auris Infections. N Engl J Med. 2024;391(20):1924-35.  https://doi.org/10.1056/NEJMra2402635  PMID: 39565991 
  2. Chowdhary A, Jain K, Chauhan N. Candida auris Genetics and Emergence. Annu Rev Microbiol. 2023;77(1):583-602.  https://doi.org/10.1146/annurev-micro-032521-015858  PMID: 37406342 
  3. Carolus H, Sofras D, Boccarella G, Sephton-Clark P, Biriukov V, Cauldron NC, et al. Acquired amphotericin B resistance leads to fitness trade-offs that can be mitigated by compensatory evolution in Candida auris. Nat Microbiol. 2024;9(12):3304-20.  https://doi.org/10.1038/s41564-024-01854-z  PMID: 39567662 
  4. Kim HY, Nguyen TA, Kidd S, Chambers J, Alastruey-Izquierdo A, Shin JH, et al. Candida auris-a systematic review to inform the world health organization fungal priority pathogens list. Med Mycol. 2024;62(6):myae042.  https://doi.org/10.1093/mmy/myae042  PMID: 38935900 
  5. Suphavilai C, Ko KKK, Lim KM, Tan MG, Boonsimma P, Chu JJK, et al. Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe. 2024;5(9):100878.  https://doi.org/10.1016/S2666-5247(24)00101-0  PMID: 39008997 
  6. Chow NA, Muñoz JF, Gade L, Berkow EL, Li X, Welsh RM, et al. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses. MBio. 2020;11(2):e03364-19.  https://doi.org/10.1128/mBio.03364-19  PMID: 32345637 
  7. Desnos-Ollivier M, Fekkar A, Bretagne S. Earliest case of Candida auris infection imported in 2007 in Europe from India prior to the 2009 description in Japan. J Mycol Med. 2021;31(3):101139.  https://doi.org/10.1016/j.mycmed.2021.101139  PMID: 33965885 
  8. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(1):35.  https://doi.org/10.1186/s13756-016-0132-5  PMID: 27777756 
  9. Kohlenberg A, Monnet DL, Plachouras D, Candida auris survey collaborative group, Candida auris survey collaborative group includes the following national experts. Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021. Euro Surveill. 2022;27(46):2200846.  https://doi.org/10.2807/1560-7917.ES.2022.27.46.2200846  PMID: 36398575 
  10. Meletiadis J, Siopi M, Spruijtenburg B, Georgiou PC, Kostoula M, Vourli S, et al. Candida auris fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023. Euro Surveill. 2024;29(45):2400128.  https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400128  PMID: 39512169 
  11. Driemeyer C, Falci DR, Hoenigl M, Cornely OA, Chakrabarti A, Gangneux JP, et al. The current state of Clinical Mycology in Eastern and South-Eastern Europe. Med Mycol. 2022;60(4):myac017. PMID: 35195256 
  12. De Carolis E, Vella A, Vaccaro L, Torelli R, Posteraro P, Ricciardi W, et al. Development and validation of an in-house database for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based yeast identification using a fast protein extraction procedure. J Clin Microbiol. 2014;52(5):1453-8.  https://doi.org/10.1128/JCM.03355-13  PMID: 24554755 
  13. de Groot T, Spruijtenburg B, Parnell LA, Chow NA, Meis JF. Optimization and Validation of Candida auris Short Tandem Repeat Analysis. Microbiol Spectr. 2022;10(5):e0264522.  https://doi.org/10.1128/spectrum.02645-22  PMID: 36190407 
  14. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589-95.  https://doi.org/10.1093/bioinformatics/btp698  PMID: 20080505 
  15. Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J, et al. Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect. 2022;11(1):2405-11.  https://doi.org/10.1080/22221751.2022.2125349  PMID: 36154919 
  16. European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST Definitive Document E.Def 7.4. Copenhagen: EUCAST; 2023. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Files/EUCAST_E.Def_7.4_Yeast_definitive_revised_2023.pdf
  17. Meletiadis J, Guinea J, Arikan-Akdagli S, Meijer EFJ, Meis JF, Cavling Arendrup M. A multicentre study for determination of epidemiological cutoff values for rezafungin and four comparators against Candida auris with EUCAST broth microdilution reference methodology. [Poster]. Presented at ESCMID Global 2025. 11-15 April 2025. Vienna, Austria. Poster no. 06753
  18. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 4th ed. CLSI standard M27. Wayne, PA: CLSI; 2017.
  19. Hou X, Lee A, Jiménez-Ortigosa C, Kordalewska M, Perlin DS, Zhao Y. Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris. Antimicrob Agents Chemother. 2018;63(1):e01811-8.  PMID: 30397051 
  20. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24-6.  https://doi.org/10.1038/nbt.1754  PMID: 21221095 
  21. Abbey DA, Funt J, Lurie-Weinberger MN, Thompson DA, Regev A, Myers CL, et al. YMAP: a pipeline for visualization of copy number variation and loss of heterozygosity in eukaryotic pathogens. Genome Med. 2014;6(11):100.  https://doi.org/10.1186/s13073-014-0100-8  PMID: 25505934 
  22. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. Available from: http://www.Rproject.org/
  23. Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2025;25(5):e280-93.  https://doi.org/10.1016/S1473-3099(24)00749-7  PMID: 39956121 
  24. Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2015;373(15):1445-56.  https://doi.org/10.1056/NEJMra1315399  PMID: 26444731 
  25. Meijer EFJ, Voss A. Should all hospitalised patients colonised with Candida auris be considered for isolation? Euro Surveill. 2024;29(45):2400729.  https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400729  PMID: 39512165 
  26. Dinh A, McNally M, D’Anglejan E, Kilu CM, Lourtet J, Ho R, et al. Correction to: Prosthetic Joint Infections due to Candida Species: A Multicenter International Study. Clin Infect Dis. 2024;79(5):1324.  https://doi.org/10.1093/cid/ciae492  PMID: 39387716 
  27. Society for Medical Microbiology. Candida auris - doporučení pro Českou republiku pod záštitou tří referenčních laboratoří a pracovní skupiny pro mykologii. [Candida auris - recommendations for Czechia endorsed by three reference laboratories and the working group for mycology]. 20 May 2025 Czech. Available from: https://www.splm.cz/article/candida-auris-doporuceni-pro-ceskou-republiku-pod-zastitou-tri-referencnich-laboratori-a-pracovni-skupiny-pro-mykologii
  28. Kappel D, Gifford H, Brackin A, Abdolrasouli A, Eyre DW, Jeffery K, et al. Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant Candida auris. Npj Antimicrob Resist. 2024;2(1):26.  https://doi.org/10.1038/s44259-024-00043-6  PMID: 39359891 
  29. Kekana D, Naicker SD, Shuping L, Velaphi S, Nakwa FL, Wadula J, et al. Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa. Emerg Infect Dis. 2023;29(10):2044-53.  https://doi.org/10.3201/eid2910.230181  PMID: 37735719 
  30. Spruijtenburg B, Nobrega de Almeida Júnior J, Ribeiro FC, Kemmerich KK, Baeta K, Meijer EFJ, et al. Multicenter Candida auris outbreak caused by azole-susceptible clade IV in Pernambuco, Brazil. Mycoses. 2024;67(6):e13752.  https://doi.org/10.1111/myc.13752  PMID: 38880933 
  31. Spruijtenburg B, Ahmad S, Asadzadeh M, Alfouzan W, Al-Obaid I, Mokaddas E, et al. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates. Mycoses. 2023;66(12):1079-86.  https://doi.org/10.1111/myc.13655  PMID: 37712885 
  32. Spruijtenburg B, Meis JF, Verweij PE, de Groot T, Meijer EFJ. Short Tandem Repeat Genotyping of Medically Important Fungi: A Comprehensive Review of a Powerful Tool with Extensive Future Potential. Mycopathologia. 2024;189(5):72.  https://doi.org/10.1007/s11046-024-00877-8  PMID: 39096450 
  33. Lin HY, Pang MY, Feng MG, Ying SH. A peroxisomal sterol carrier protein 2 (Scp2) contributes to lipid trafficking in differentiation and virulence of the insect pathogenic fungus Beauveria bassiana. Fungal Genet Biol. 2022;158:103651.  https://doi.org/10.1016/j.fgb.2021.103651  PMID: 34906632 
  34. Zhang L, Xiao M, Watts MR, Wang H, Fan X, Kong F, et al. Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy. BMC Infect Dis. 2015;15(1):340.  https://doi.org/10.1186/s12879-015-1086-6  PMID: 26282840 
  35. Burrack LS, Todd RT, Soisangwan N, Wiederhold NP, Selmecki A. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo. MBio. 2022;13(4):e0084222.  https://doi.org/10.1128/mbio.00842-22  PMID: 35862787 
  36. Bottery MJ, van Rhijn N, Chown H, Rhodes JL, Celia-Sanchez BN, Brewer MT, et al. Elevated mutation rates in multi-azole resistant Aspergillus fumigatus drive rapid evolution of antifungal resistance. Nat Commun. 2024;15(1):10654.  https://doi.org/10.1038/s41467-024-54568-5  PMID: 39681549 
  37. Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D, et al. Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nat Commun. 2016;7(1):11128.  https://doi.org/10.1038/ncomms11128  PMID: 27020939 
/content/10.2807/1560-7917.ES.2025.30.45.2500285
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error